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Novel, Synergistic Antifungal 
Combinations that Target 
Translation Fidelity
Elena Moreno-Martinez, Cindy Vallieres, Sara L. Holland & Simon V. Avery
There is an unmet need for new antifungal or fungicide treatments, as resistance to existing 
treatments grows. Combination treatments help to combat resistance. Here we develop a novel, 
effective target for combination antifungal therapy. Different aminoglycoside antibiotics combined 
with different sulphate-transport inhibitors produced strong, synergistic growth-inhibition of 
several fungi. Combinations decreased the respective MICs by ≥8-fold. Synergy was suppressed in 
yeast mutants resistant to effects of sulphate-mimetics (like chromate or molybdate) on sulphate 
transport. By different mechanisms, aminoglycosides and inhibition of sulphate transport cause 
errors in mRNA translation. The mistranslation rate was stimulated up to 10-fold when the agents 
were used in combination, consistent with this being the mode of synergistic action. A range of 
undesirable fungi were susceptible to synergistic inhibition by the combinations, including the 
human pathogens Candida albicans, C. glabrata and Cryptococcus neoformans, the food spoilage 
organism Zygosaccharomyces bailii and the phytopathogens Rhizoctonia solani and Zymoseptoria 
tritici. There was some specificity as certain fungi were unaffected. There was no synergy against 
bacterial or mammalian cells. The results indicate that translation fidelity is a promising new target 
for combinatorial treatment of undesirable fungi, the combinations requiring substantially decreased 
doses of active components compared to each agent alone.
Diverse fungi are considered undesirable, including human and animal (livestock) pathogens, crop path-
ogens, food spoilage fungi and fungi causing deterioration of materials or indoor air quality. Fungal 
pathogens cause as many or more deaths than drug-resistant tuberculosis and malaria1. Among the most 
important opportunistic fungal pathogens of humans are Candida spp. the fourth most common cause 
of nosocomial infection, with a mortality rate close to 34%2. Other common fungal pathogens include 
Aspergillus, Cryptococcus and Pneumocystis spp. In addition, fungi can be devastating pathogens of food 
crops and other plants. Reflecting this, the global fungicide market is worth more than $7 billion3,4. Up 
to one third of all foods is spoiled by fungi, the majority of this being stored agricultural products5,6. 
A range of antifungals or fungicides have been developed to counter such undesirable fungi4,7. Drugs 
used for treatment of fungal infections include the polyenes, azoles and echinocandins. A wider range 
of fungicides have been approved for use against phytopathogens, including metal-based compounds. 
Certain antibiotics are still approved as fungicides in some countries despite concerns about spread of 
antibiotic resistance.
Evolution of resistance to antifungals and particularly fungicides is a growing problem, underscoring 
the urgent need for development of new effective treatments4,7. Combination treatments are attracting 
particular attention as a method of management. An advantage of such combinations is that they reduce 
the likelihood of resistance: evolution of resistance to more than one agent is much slower than with a 
single agent8,9. Such combinations can be particularly effective where they produce a synergistic action 
against the fungus. This allows lower doses of the agents to be used than if supplied singly, lessening 
potential concerns over non-specific toxicity or cost. For example, the minimal inhibitory concentration 
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of the antifungal caspofungin could be decreased by up to 5-fold in combination with a cheap drug 
(chloroquine) with which there was synergistic inhibition10. Such strong synergies are not very common, 
but their detection is facilitated by screening approaches (chemical or biological) and/or the use of a 
good model system. The yeast Saccharomyces cerevisiae is widely adopted as a eukaryotic cell model of 
choice and has been applied to characterize the actions of antifungal drugs10,11 as well as a diverse range 
of other therapeutic compounds12–15.
In previous work with S. cerevisiae to characterise mode-of-action of the metal toxicant chromate, 
synergistic inhibition of yeast growth was observed when chromate was combined with the aminogly-
coside antibiotic paromomycin16. For the purposes of that study, this result among others helped to 
establish that chromate treatment provokes errors in the process of mRNA translation during protein 
synthesis, producing toxic protein aggregates. For the purposes of the present study, we re-evaluate that 
observed synergy from the perspective of its antifungal potential. Whereas aminoglycosides are com-
monly used as antibacterials due to the sensitivity of prokaryotic ribosomes, at elevated doses they also 
target eukaryotic ribosomes and so can inhibit fungi, with some aminoglycosides used as fungicides17–19. 
As mentioned above, certain metal-based compounds have also been approved for crop protection. Here, 
first we exploit S. cerevisiae to elucidate alternative agents that can be combined synergistically with 
paromomcyin or chromate, lowering their effective concentrations, and we describe the mechanism of 
synergistic inhibition. Moreover, we show that the combinations are highly effective at inhibiting growth 
of certain major pathogenic and food-spoilage fungi; the subject of a GB (priority) patent application 
(25-03-2015). It is proposed that combination targeting of translation fidelity can offer an effective strat-
egy for controlling fungal growth.
Results
Aminoglycosides combined with sulphate transport inhibitors produce synergistic inhibition 
of yeast growth. The aminoglycoside paromomycin and the toxic metal chromate were each sup-
plied at sub-inhibitory concentrations. When combined, these produced almost complete inhibition of 
growth of the model yeast S. cerevisiae (Fig. 1A). Synergy is evident where the growth inhibition effect 
is significantly greater with the agents combined than by a simple product of their individual effects at 
the same doses. Synergy with Cr was not specific to paromomycin. Streptomycin and hygromycin as 
alternative aminoglycosides also both produced strong synergistic growth inhibition when combined 
with Cr (Fig. 1A). Checkerboard analysis showed that combinations decreased the MICs of the individ-
ual agents by ≥ 8-fold in the cases of either paromomycin or streptomycin with Cr, and by ≥ 4-fold for 
hygromycin with Cr (Fig. 1B). Mean fractional inhibitory concentrations (FIC) for these combinations 
were calculated to be 0.17, 0.25 and 0.29 respectively; combinations are normally considered synergistic 
when the mean FIC is ≤ 0.5020.
Figure 1. Aminoglycosides combined with chromate produce synergistic inhibition of yeast growth. 
(A) Growth of S. cerevisiae BY4743 was monitored continuously in YEPD broth supplemented as indicated. 
The agents and doses were: paromomycin (Parom), 200–250 μ g ml−1; hygromycin B (Hygro), 10 μ g ml−1; 
streptomycin (Strep), 30 mg ml−1 (the highest soluble dose attainable); chromate (Cr), 50 μ M. Data shown 
are replicates from two independent cultures ± SEM where these are larger than the symbol dimensions. 
The data for each condition are representative of at least two independent experiments performed on 
different days. (B) Checkerboard assays with S. cerevisiae at the indicated concentrations, according to 
EUCAST procedure. The growth values within the boxes are percentages of control growth (OD) determined 
in the absence of aminoglycoside or Cr. Shaded boxes indicate ≥ 50% of control growth.
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The stimulation of mRNA mistranslation by Cr has been indicated previously to arise from interfer-
ence with sulphate uptake, leading to a limitation for (biosynthesis of) sulphur containing amino acids21. 
Therefore we tested alternative agents reported to interfere with sulphate transport or metabolism22, each 
in combination with paromomycin, streptomycin or hygromycin. The combination giving the strongest 
effect with each sulphate transport inhibitor is presented (Fig.  2) with the other combinations in the 
supplementary material (Supplementary Fig. S1). Sodium molybdate produced synergistic inhibition 
of yeast growth with aminoglycosides, particularly hygromycin. A comparatively high molybdate dose 
was used (1 mM) as it is less toxic than chromate. At a similar concentration, sodium orthovanadate 
gave strong growth inhibition in combination with streptomycin (Fig.  2), with the effect a little less 
marked in combinations with paromomycin and particularly hygromycin (Supplementary Fig. S1). There 
was also synergy between hygromycin and the anion exchange inhibitor 4,4′ -diisothio-cyanatostilbene
-2,2′ -disulphonate (DIDS) (Fig.  2). There was weaker evidence for synergistic growth inhibition with 
sodium-bicarbonate (most effective with streptomycin), -oxalate or -malonate (most effective with paro-
momycin). We found no evidence for synergy in yeast when aminoglycosides were combined with cer-
tain putative sulphate-transport inhibitors: selenate, thiosulphate, tungstate or tetrathionate (data not 
shown). The results showed that a number of alternative aminoglycosides in combination with a number 
of alternative sulphate transport inhibitors produce synergistic growth inhibition of yeast.
Synergy is suppressed in mutants resistant to sulphate-transport inhibition. To test the 
hypothesis that the mechanism of synergy involved perturbation of sulphate supply, first we used an 
S. cerevisiae cys3Δ/met15Δ mutant. This mutant takes up cysteine and methionine directly from the 
growth medium, rather than synthesis in the cell from transported sulphate, so is resistant to effects of 
chromate on sulphate uptake and on translation error21. Supporting the hypothesis, synergistic growth 
inhibition by paromomycin and Cr was rescued in the cys3Δ/met15Δ mutant (Fig. 3). Synergistic growth 
inhibition by paromomycin combined with an alternative sulphate mimetic, molybdate, also was largely 
Figure 2. Aminoglycosides combined with sulphate transport inhibitors produce synergistic inhibition 
of yeast growth. Growth of S. cerevisiae BY4743 was monitored continuously in YEPD broth (or YNB broth 
for Hygro+ DIDS, as DIDS formed precipitates in YEPD), supplemented with different aminoglycosides in 
combination with sulphate transport inhibitors (the most effective synergistic combinations are presented; 
other combinations are in Supplementary Fig. S1). Aminoglycoside doses were as for Fig. 1 except in 
combination with DIDS where hygromycin B was at 150 μ g ml−1. The sulphate transport inhibitors were 
chromate (Cr), 50 μ M; molybdate (Mo), 1 mM, orthovanadate (Orthovan), 1 mM; DIDS, 1 mM; malonate 
(Mal), 50 mM (the highest sub-inhibitory dose tested); oxalate (Ox), 5 mM (the highest soluble dose 
attainable); bicarbonate (Bic), 7.5 mM. Data shown are replicates from two independent cultures ± SEM 
where these are larger than the symbol dimensions. The data for each condition are representative of at least 
two independent experiments performed on different days.
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suppressed in the cys3Δ/met15Δ mutant (Fig. 3). In the case of hygromycin B combined with DIDS, a 
more general anion transport inhibitor, synergy seen in the wild type was not abolished in the mutant 
(Fig.  3). The results are consistent with inhibition of sulphate-transport being the relevant, underlying 
mechanism of synergy for Cr or Mo with paromomycin.
The yeast membrane-transport proteins Sul1 and Sul2 are the sites at which chromate competes with 
sulphate for uptake23 and a sul1Δ/sul2Δ mutant is resistant to this competitive action21. Corroborating 
that the synergy with aminoglycosides involves inhibition of sulphate transport, synergy between chro-
mate or molybdate and paromomycin was suppressed in the sul1Δ/sul2Δ mutant, even at elevated paro-
momycin concentrations (Fig.  3). Unlike results for the cys3Δ/met15Δ mutant, deletion of SUL1 and 
SUL2 was also effective in suppressing synergy between hygromycin B and DIDS.
The translation error-rate is synergistically increased by combining aminoglycoside with sul-
phate transport inhibitor. Whereas chromate is thought to cause translation errors by limiting the 
availability of sulphur-containing amino acids for cognate tRNAs16,21,24, aminoglycosides like paromo-
mycin are thought to induce a structural alteration in the small ribosomal subunit decoding centre18,25. 
Since parallel mechanisms like this which target a single phenotype are a common basis for drug-drug 
synergies, we tested whether the synergistic growth inhibition (Figs 1 and 2) was reflected by synergistic 
mistranslation. First we used a qualitative assay, based on translational read-through of a premature stop 
codon carried in the ade1-14 allele of S. cerevisiae L149416. Read-through suppresses the red pigmenta-
tion associated with this allele. Cr, Mo or DIDS alone had negligible effect on red-colony phenotype at 
the doses used, but in combination with aminoglycosides produced a slightly paler colour than amino-
glycoside alone, suggesting read-through (Fig. 4A).
Figure 3. Synergy is suppressed in mutants resistant to sulphate-transport inhibition. Growth of wild 
type S. cerevisiae BY4741 or isogenic cys3Δ/met15Δ or sul1Δ/sul2Δ mutants was monitored continuously 
in YEPD or YNB (for Hygro+ DIDS) broths. The appropriate doses of indicated agents used to test synergy 
were: 50 μ g ml−1 paromomycin for wild type and cys3Δ/met15Δ, 300 μ g ml−1 paromomycin for sul1Δ/
sul2Δ, 150 μ g ml−1 hygromycin B, 50 μ M chromate, 1 mM molybdate, 1 mM DIDS. Data shown are 
replicates from two independent cultures ± SEM where these are larger than the symbol dimensions. The 
data for each condition are representative of at least two independent experiments performed on different 
days.
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For a quantitative indication of mistranslation synergy, the rate of translational read-through of a 
UAA nonsense (stop) codon was monitored in a short-term dual-luciferase assay16. The plasmid borne 
construct used for this assay encodes a Renilla luciferase followed by a firefly luciferase with these ORFs 
separated by the UAA stop codon. The firefly luciferase should only be expressed following inappropriate 
read-through of the stop codon. Therefore, the measured ratio of the firefly to Renilla luciferase activities 
indicates the rate of mistranslation. The rate of read-through was increased ∼ 5-fold by a combination of 
Cr and paromomycin, in conditions where neither agent alone had a strong effect at the doses used (each 
agent alone causes read-through at higher doses) (Fig. 4B). A synergistic elevation of mistranslation rate 
was also obtained for the paromomycin-Mo and hygromycin-DIDS combinations. Consistent with the 
growth results (Fig. 3), synergistic mistranslation (by paromomycin and Cr or Mo) was abolished in a 
Figure 4. The translation error-rate is synergistically increased by combining paromomycin with 
sulphate mimetics. (A) S. cerevisiae L1494 (ade1-14) cells in 10-fold serial dilutions were spotted and 
incubated on YEPD agar supplemented with 25 μ g ml−1 paromomycin, 50 μ M chromate and/or 250 μ M 
molybdate, or to YNB agar with 100 μ g ml−1 hygromycin B and/or 1 mM DIDS. (B) Wild type yeast 
transformed with the dual-luciferase plasmid36 were exposed to 50 μ g ml−1 aminoglycoside and/or 100 μ M 
chromate, 500 μ M molybdate, or 1 mM DIDS in YNB broth before determination of firefly and Renilla 
luciferase activities in protein extracts. The ratio of these activities indicates the level of translation read-
through of the UAA stop codon separating the two ORFs. All values are means ± SEM from at least three 
independent determinations. RLU, relative light units. (C) The isogenic cys3Δ/met15Δ and sul1Δ/sul2Δ 
yeast double-deletants were treated as in (B). *p < 0.05 and **p < 0.01, according to one-way ANOVA.
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cys3Δ/met15Δ or sul1Δ/sul2Δ mutant (Fig. 4C). (We did not test mistranslation for DIDS with these 
mutants as the corresponding growth results were mixed; Fig.  3). The results are consistent with the 
hypothesis that combined targeting of translation fidelity causes synergistic growth inhibition by the 
sulphate mimetics combined with aminoglycoside.
Sensitivity of pathogenic and food-spoilage fungi to combinatorial inhibition. The effects 
of aminoglycoside in combinations with a sulphate mimetic were tested against key fungi of interest. 
Again, agents were supplied at doses which, individually, were near sub-inhibitory to each of the fungi. 
Accordingly, inclusion of either 25 μ M chromate or 10 μ g ml−1 hygromycin had no discernible inhibitory 
effect on growth of the human pathogen Candida albicans (Fig. 5A). However, growth yield was reduced 
≥ 90% when the two agents were supplied in combination. Chromate also inhibited C. albicans in com-
bination with paromomycin. Checkerboard analysis corroborated that these combinations decreased the 
MICs of the individual agents by ≥ 16-fold (Supplementary Fig. S2A). Molybdate was highly inhib-
itory to C. albicans in combination with paromomycin or hygromycin (Supplementary Fig. S2B). 
Sodium-bicarbonate and -orthovanadate were also tested, but did not produce synergy with aminoglyco-
sides against C. albicans (data not shown). Some synergistic growth inhibition by paromomycin and Cr 
was also evident with another pathogenic Candida species, C. glabrata, although the effect on cell dou-
bling time did not become apparent until mid-exponential growth (∼ 6 h) (Fig. 5B). Combinations of Cr 
with paromomycin or hygromycin (Fig. 5C) and to some extent streptomycin (Supplementary Fig. S2C) 
gave effective synergistic inhibition of the pathogenic yeast Cryptococcus neoformans. We did not detect 
obvious synergy between paromomycin and Cr against the filamentous fungi Aspergillus fumigatus 
(human pathogen) or Botrytis cinerea (plant pathogen), where the effect of the combination was not 
significantly different from that which could be accounted for by an additive effect of the individual treat-
ments (Supplementary Fig. S3). Importantly, non-fungal test organisms were not sensitive to the synergy: 
neither the bacterium E. coli nor a human cell line exhibited synergistic inhibition by the combination 
(Supplementary Fig. S3; note the concentration of paromomycin alone that was just sub-inhibitory to 
E. coli was particularly low owing to this organism’s paromomycin hyper-sensitivity). There was syn-
ergistic growth inhibition of the food spoilage yeast Zygosaccharomyces bailii (Fig.  6A). Most dilutions 
Figure 5. Synergistic growth inhibition of fungi pathogenic to humans. (A) Growth of C. albicans 
in YEPD broth supplemented with 200 μ g ml−1 paromomycin, 10 μ g ml−1 hygromycin B and/or 25 μ M 
chromate. (B) Growth of C. glabrata in YEPD broth supplemented with 400 μ g ml−1 paromomycin and/or 
50 μ M chromate. (C) Growth of Cryptococcus neoformans in YEPD broth supplemented with 12.5 μ g ml−1  
paromomycin, 0.625 μ g ml−1 hygromycin B and/or 12.5 μ M chromate. Data shown are replicates from 
two independent cultures ± SEM where these are larger than the symbol dimensions. The data for each 
condition are representative of at least two independent experiments performed on different days.
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of Z. bailii cell suspensions showed little growth on agar supplemented with paromomycin and chro-
mate, at concentrations where neither agent alone had a marked growth effect. We additionally tested 
the molybdate-paromomycin and hygromycin-DIDS combinations against Z. bailii, with similar results. 
Synergistic growth inhibition of the fungal plant pathogen Rhizoctonia solani was also evident (Fig. 6B). 
Radial growth of R. solani from a central, point inoculum on agar was compromised by incorporation 
of paromomycin and molybdate into the medium, supplied at concentrations where neither individual 
agent had a marked growth-inhibitory effect. Similarly, growth yield of the plant pathogen Zymoseptoria 
tritici was synergistically inhibited by up to 90% using combinations of chromate (but not molybdate) 
with paromomycin or hygromycin B (but not streptomycin) (Fig. 6C). The results show that a number 
of important undesirable fungi are hyper-sensitive to targeting of translation fidelity using combinations 
of aminoglycoside with certain sulphate transport inhibitors.
Discussion
Within a previous study, it was observed that paromomycin and chromate synergistically inhibit growth 
of the laboratory yeast S. cerevisiae16. The present results establish that other aminoglycosides besides 
paromomycin are effective in the combination and that impact on sulphate transport is the relevant prop-
erty of chromate, as other sulphate-mimetics were also effective and appropriate mutants abolished the 
synergy. The evidence also indicates that amplification of translation error-rate is the mode of synergistic 
action. Moreover, certain major pathogenic and food spoilage fungi are susceptible to the combinations. 
We propose that combination targeting of translation fidelity offers a new potential strategy for managing 
such fungi.
Synergistic effects of more than one agent are commonly seen where they target a common process 
but by different mechanisms or pathways26. This appears to be the case here. Aminoglycosides are thought 
to promote translation errors by causing a structural alteration in the small ribosomal subunit decoding 
centre, allowing entry of near-cognate tRNAs18,25. On the other hand, chromate (and presumably related 
sulphate mimetics) compete with sulphate for uptake, leading to starvation for sulphur-containing amino 
acid acids and mistranslation21,23. This dual targeting of translation fidelity was effective in synergistically 
Figure 6. Synergistic growth inhibition of other problem fungi. (A) Growth of Z. bailii after spotting 10-
fold serial dilutions of cell suspension on YEPD agar supplemented with 10 μ g ml−1 paromomycin, 50 μ M 
chromate and/or 1 mM molybdate, or to YNB agar with 10 μ g ml−1 hygromycin B and/or 250 μ M DIDS.  
(B) Growth of R. solani on PDA agar supplemented with 300 μ g ml−1 paromomycin and 15 mM molybdate. 
(C) Growth of Z. tritici in PDB medium supplemented with 0.5 μ g ml−1 paromomycin, 0.25 μ g ml−1 
hygromycin B and/or 10 μ M chromate. The data for each condition are representative of at least two 
independent experiments performed on different days.
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increasing translation error-rate and decreasing growth rate. Such types of combination are particularly 
useful for antimicrobial application as they decrease not only the risk of resistance evolution8,27 but the 
synergy also allows much lower amounts of active agents to be used. Translation fidelity is a particularly 
attractive target as its effects are not simply due to loss of essential (protein) functions, but also gain of 
toxic function through formation of inhibitory protein aggregates16.
The actual concentrations that were effective here varied depending on the aminoglycoside used, the 
sulphate-mimetic, the fungus and the growth medium. Clearly, the lower the effective concentrations, 
the more desirable in any application as this lessens potential concerns over non-specific toxicity or cost; 
even when the agents are relatively cheap, as is largely the case here. As certain of the agent types used 
here already have had some application singly, decreasing their effective concentrations in a combined 
approach can only alleviate any concerns over dosage levels. In several cases, concentrations that gave 
little or no inhibition individually were sufficient to give close to 100% growth inhibition when used 
in combination; with MICs decreased ≥ 8-fold in the combinations, some synergistic growth inhibi-
tion was still achievable at considerably lower doses in many of these examples. It is also important to 
note that the screen of aminoglycosides and sulphate mimetics was not exhaustive and other analogues 
effective in the combination with different MICs are likely to be found. This is particularly true for 
any non-competitive inhibitors of the relevant sulphate transporters which, being non-competitive, may 
require lower doses to be effective than the competitive inhibitors used here. Finally, it is important to 
note that the in vitro conditions used for the present tests were valuable for demonstrating the synergy 
against different fungi and for elucidating mode-of-action, but effective concentrations are likely to vary 
considerably in different plant or animal tissues and other environments requiring fungal control28,29.
Specificity for target organisms is a key consideration for any antimicrobial treatment. Like other 
agents, aminoglycosides and sulphate-mimetics may of course ultimately inhibit any organism given 
sufficiently high doses. Relatively low concentrations of aminoglycosides are commonly needed to inhibit 
Gram negative bacteria, the usual target organisms for these antibiotics. However, neither E. coli nor a 
human cell line exhibited sensitivity to the synergistic action of aminoglycoside in combination with 
sulphate-mimetic. The potential impact of sulphate-mimetics (or sulphate starvation) on translation 
error in these organisms has not been investigated to our knowledge. Given that sulphate uptake is not 
necessary for supply of methionine (essential) or cysteine (conditionally essential) in humans, there is 
no rationale for expecting sulphate-mimetics to provoke mistranslation in this case. In other words, a 
mechanistic requirement for the synergy to work in fungi is absent in humans, consistent with the syn-
ergistic activity being target specific. One apparent inconsistency among the mechanism-of-action data 
was the observation that deletion of SUL1+ SUL2 but not of CYS3+ MET15 suppressed synergy between 
hygromycin and DIDS in yeast. The most straightforward explanation is that DIDS also interferes with 
Cys or Met transport, which would preclude these supplements from rescuing a blockage by DIDS of 
Sul1/Sul2-dependent sulphate availability. Given that DIDS is a general anion exchange inhibitor, in 
contrast to chromate and molybdate tested here specifically as sulphate mimetics, it is reasonable to 
expect that DIDS would be the most likely to exert non-specific effects, e.g. on processes impacting Cys 
or Met transport30.
Among the fungi tested, there was variation in the combinations that were most effective and the rela-
tive degree of sensitivity attained. All five of the yeasts showed sensitivity, in contrast to only R. solani and 
Z. tritici of the four filamentous fungi tested with the paromomycin and chromate combination. As the 
only basidiomycetes tested, R. solani and C. neoformans are less closely related to the other yeasts phy-
logenetically than the combination-resistant filamentous fungi B. cinerea or A. fumigatus (ascomycetes)31. 
All of the fungi tested express orthologues of the yeast Sul1 and/or Sul2 proteins, the predicted site of 
action of the sulphate mimetics21. Orthologue identity with the yeast protein sequences is slightly greater 
for R. solani (43 and 44% identity) than A. fumigatus or B. cinerea (38–41% identity). On this basis, of the 
four filamentous fungi it is R. solani and Z. tritici that cluster most closely with the combination-sensitive 
yeasts (Supplementary Fig. S4), suggesting that sequence similarity to the yeast Sul1/Sul2 proteins could 
provide a predictor of sensitivity.
The potential of translation fidelity as a target for combinatorial inhibition of fungal growth is exem-
plified by the present results for Z. bailii. This organism is notoriously resistant to agents like weak acids, 
commonly used for control of food spoilage by yeasts32. Z. bailii was hyper-sensitive to inhibition in this 
study, requiring comparatively low concentrations of aminoglycoside in the combinations to achieve 
synergy. Whereas regulatory constraints would preclude the use of many of the agents described here 
to control Z. bailii in foods intended for human consumption, such constraints are less of an issue for 
other applications in fungal control, such as building-mould or fungal plant disease; the wheat pathogen 
Z. tritici was also hyper-sensitive to synergy at low doses. Aminoglycosides are already approved and 
widely used as anti-infectives in humans. Moreover, as this work establishes translation fidelity as a 
potential combinatorial target, it opens the door to discovery of alternative agents that can be substituted 
to achieve similar (or better) synergy and more-tailored activity spectra and safety profiles.
Methods
Fungal strains and maintenance. Mode of action studies were performed primarily with 
Saccharomyces cerevisiae BY4743 or, for experiments involving the cys3Δ/met15Δ and sul1Δ/sul2Δ 
mutants21, the isogenic haploid BY4741. S. cerevisiae L1494 (ade1-14) was used for red/white mistranslation 
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assays (below). Other fungi were the yeasts Candida albicans SC5314, Candida glabrata BG2, Cryptococcus 
neoformans 1841 and Zygosaccharomyces bailii NCYC 1766, and the filamentous fungi Aspergillus fumig-
atus Af293, Botrytis cinerea SAR109940, Rhizoctonia solani AG2-1 1939 and Zymoseptoria tritici. The 
yeasts were routinely grown and maintained on YEPD medium: 1% (w/v) yeast extract (Oxoid), 2% 
(w/v) peptone (Oxoid), 2% (w/v) glucose. Where specified, yeasts were cultured in YNB medium [0.69% 
yeast-nitrogen base without amino acids (Formedium), 2% (w/v) D-glucose], supplemented as required 
with amino acids or nucleobases to complement auxotrophies or for plasmid selection. Where necessary, 
media were solidified with 2% (w/v) agar (Sigma-Aldrich, St. Louis, MO). The filamentous fungi were 
routinely maintained and grown on potato dextrose agar (PDA; Oxoid) except A. fumigatus which was 
on Aspergillus complete medium (ACM)33.
Chemicals. With the exception of hygromycin B (Panreac Applichem), all chemicals were from 
Sigma-Aldrich: paromomycin, streptomycin, Na2CrO4, Na2MoO4, Na3VO4, 4,4′ -diisothio-cyanatostilbene
-2,2′ -disulphonate (DIDS), sodium malonate, sodium oxalate, NaHCO3, Na2SeO4, Na2S2O3, Na2WO4, 
Na2S4O6. With the exception of DIDS (in 0.1 M potassium bicarbonate), stock solutions of all chemicals 
used to inhibit growth were prepared in distilled water and added to growth media at the specified final 
concentrations. All stock solutions were filter-sterilized before additions to media.
Inhibition assays in broth. Yeasts were inoculated from YEPD plates to YEPD broth and cultured 
overnight at 30 °C, 120 rev min−1. Overnight cultures were diluted to OD600~0.5 and cultured for a 
further 4 h in fresh YEPD before dilution of these experimental cultures to OD600~0.01 or ~0.1 in the 
same medium. Aliquots (300 μ l) of the diluted culture plus any chemical supplements (see above), as 
specified, were transferred to 48-well plates (Greiner Bio-One). OD600 was monitored continuously in a 
BioTek Powerwave-XS microplate spectrophotometer, with shaking at 30 C. Escherichia coli was tested 
in a similar way but with growth in LB broth and at 37 C. Spores of Z. tritici were inoculated from PDA 
plates to potato dextrose broth (PDB; Fluka) (20,000 spores ml−1). Aliquots (150 μ l) of the diluted culture 
plus any chemical supplements, as specified, were transferred to 96-well plates (Greiner Bio-one) and 
cultured over 8 d at 24 °C, 120 rev min−1. OD600 was monitored every day in a BioTek EL800 microplate 
spectrophotometer. Human TE671 cells were cultured in DMEM supplemented with 10% foetal bovine 
serum, L-glutamine (2 mM), penicillin (100 U ml−1), streptomycin (100 μ g ml−1) in 25 cm2 cell culture 
flasks, 36.5 °C, 5% oxygen. Cells were detached with trypsin/EDTA and washed in 10 ml DMEM. Then 
100 ul of cell suspension (in DMEM without antibiotics) were dispensed to 5000 cells/well in a 96-well 
plate. After 24 h, paromomycin or chromate were added as specified. After a further 24 h, 10 μ l of CCK-8 
reagent (Sigma) were added to each well. After 4 h incubation, formazan production was determined at 
450 nm using a BioTek EL800 microplate spectrophotometer.
Checkerboard assays. All culturing and preparation for checkerboard assays adhered to EUCAST 
guidelines34,35 with the exception that YEPD broth at 30 C was necessary to support adequate growth 
of both S. cerevisiae and C. albicans. Five colonies from PDA plates grown at 30 C for ∼ 20 h were each 
suspended in YEPD and added with solutions of inhibitors as specified in 96-well microdilution plates 
to give final suspensions of 200 μ l per well at cell densities of ∼ 1.5 × 105 ml−1. The inoculated plates 
were incubated statically for 24 h at 30 C before measurement of OD600 with a BioTek EL800 microplate 
spectrophotometer. After subtraction of the background reading from readings for the rest of the wells, 
percentage growth for each condition was calculated relative to control growth in the absence of added 
inhibitors. Fractional inhibitory concentrations (FIC) were calculated as described20.
Growth inhibition assays on solid medium. For qualitative growth-inhibition assays with Z. bailii 
on solid medium, experimental cultures prepared as described above were adjusted to OD600∼ 2.0, 0.2, 
0.02, 0.002, 0.0002 and the dilution series spotted (4 μ l) on to YEPD agar. Images were captured after 2 d 
growth at 30 C. For growth-inhibition assays on solid medium with filamentous fungi, circular sections 
of ~0.5 cm diameter were excised from cultures on PDA or ACM agar, and transferred to the centre of 
fresh plates. Images were captured after 3 d growth at 28 C and the total mycelial area determined using 
ImageJ and GIMP2 software. Where specified, chemical supplements were included in the solid media.
Mistranslation assays. For qualitative determination of mistranslation, S. cerevisiae L1494 (ade1-
14) was spotted as described above to either YEPD agar, or YNB agar in the case of DIDS/hygromycin 
(using YNB supplemented with 5 μ g ml−1 adenine rather than the standard 20 μ g ml−1). Images were 
captured for red versus white colony-colour comparisons after 2 d (YEPD) or 3 d (YNB) growth at 30 C. 
For quantitative determination of mistranslation, S. cerevisiae was transformed with a dual luciferase 
reporter plasmid encoding firefly and Renilla luciferases, the relative protein activities of which indicate 
the level of translational read-through of the UAA stop codon separating the two ORFs16,36. The organism 
was cultured as above in YNB broth appropriate for plasmid selection. Cells were exposed to specified 
agents for 3 h, before preparation of protein extracts and determination of the two luciferase activities 
as described previously16.
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